saleofmerfin8k.htm


 
 
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
 
 
 
FORM 8-K
 
 
 
 
 
CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported)
January 18, 2012
 
 
 
 
 
BUCKEYE TECHNOLOGIES INC.
(Exact name of registrant as specified in its charter)
 
 
 
 
 
         
State of Delaware
 
33-60032
 
62-1518973
(State or Other Jurisdiction
of Incorporation)
 
(Commission File Number)
 
(IRS Employer
Identification No.)
 
     
1001 Tillman Street
Memphis, Tennessee
 
38112
(Address of principal executive offices)
 
(Zip Code)
 
(901) 320-8100
Registrant’s telephone number, including area code
 
N/A
(Former name or former address, if changed since last report)
 
 
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
  
 

 
 
 

 
Item 1.01                                Entry Into a Material Definitive Agreement
 
Buckeye Technologies Inc. (NYSE:BKI) today announced that it has signed a definitive agreement to sell the assets and ongoing operations of its Merfin Systems converting business to National Tissue Company, LLC.  Merfin Systems, located in King, North Carolina, is a converter of towels, tissue and napkins which it sells along with proprietary paper product dispensers into the away from home market.  It sells these products through selected distributors concentrated in the eastern U.S. and Canada.  National Tissue is a privately owned converter located in Cudahy, Wisconsin.  National Tissue markets and sells its broad product line primarily through small and mid-sized distributors located in the Midwest.

Item 7.01                                Regulation FD Disclosure.
 
The information furnished on exhibit 99.1 is hereby incorporated by reference under this Item 7.01 as if fully set forth herein.  The information presented herein under Item 7.01 shall not be deemed "filed" under the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as may be expressly set forth by specific reference in such a filing.
 
Item 9.01                      Financial Statements and Exhibits.
 
 (d) Exhibits.
 
99.1.
  Press release dated January 18, 2012   (furnished)
   
 


 
 

 
 

 

 


 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
     
BUCKEYE TECHNOLOGIES INC.
   
By:
 
                                                                   /s/ Steven G. Dean
   
Steven G. Dean
   
Senior Vice President and Chief Financial Officer
Date: January 19, 2012